WeVote
Log In

Bill

Bill

SB 212

Schedule VI controlled substances; TPA-certified optometrists permitted to sell and dispense.

2026 Regular Session Introduced by Jennifer Boysko and 1 co-sponsor

Permits TPA-certified optometrists to sell and dispense Schedule VI controlled substances, expanding their scope of practice in Virginia.

Approved by Governor-Chapter 941 (effective 7/1/2026)
0
WeVote Research Nonpartisan
Bill Summary · SB 212

Legislative bill overview

SB 212 would permit optometrists who are certified by the Therapeutic Pharmaceutical Agent (TPA) program to sell and dispense Schedule VI controlled substances in Virginia. Currently, this authority is restricted to other healthcare providers. The bill expands the scope of practice for qualified optometrists to include these pharmaceutical products.

Why is this important

Schedule VI substances include medications commonly used in eye care, such as certain anti-inflammatory and antibiotic compounds. Expanding optometrist authority could improve patient access and convenience by allowing eye care to be more comprehensively delivered in one location, potentially reducing costs and wait times for patients seeking both exams and treatment.

Potential points of contention

  • Scope of practice boundaries: Physicians and other healthcare professions may object to further expansion of optometrist authority, viewing it as encroachment on traditionally physician-regulated pharmaceutical distribution
  • Patient safety oversight: Questions about whether optometrist training and licensure adequately prepare them for medication dispensing responsibilities, particularly around drug interactions and patient monitoring
  • Regulatory enforcement: Concerns about whether existing oversight mechanisms can effectively monitor and enforce compliance among a broader provider base dispensing controlled substances

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.